Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Maria Cinta CidSebastian H UnizonyDaniel BlockmansElisabeth BrouwerLorenzo DagnaBhaskar DasguptaBernhard HellmichEamonn MolloyCarlo SalvaraniBruce C TrapnellKenneth J WarringtonIan WicksManoj SamantTeresa ZhouLara PupimJohn F Paolininull nullPublished in: Annals of the rheumatic diseases (2022)
ClinicalTrials.gov number: NCT03827018, Europe (EUdraCT number: 2018-001003-36), and Australia (CT-2018-CTN-01 865-1).